Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment-Reference-Cited by-同舟云学术

Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment

Published:2016-05-30 Issue:3 Volume:11 Page:769-783
ISSN:1931-7557
Container-title:Brain Imaging and Behavior
language:en
Short-container-title:Brain Imaging and Behavior

Author:

Amidi Ali,Agerbæk Mads,Wu Lisa M.,Pedersen Anders D.,Mehlsen Mimi,Clausen Cecilie R.,Demontis Ditte,Børglum Anders D.,Harbøll Anja,Zachariae Robert

Funder

Kræftens Bekæmpelse

Saværksejer Jeppe Juhls og Hustru Ovita Juhls Mindelegat

Publisher

Springer Science and Business Media LLC

Subject

Behavioral Neuroscience,Psychiatry and Mental health,Cellular and Molecular Neuroscience,Clinical Neurology,Cognitive Neuroscience,Neurology,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s11682-016-9552-3/fulltext.html

Reference68 articles.

1. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192–201. doi: 10.1038/nrc2073 .

2. Ahles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., & Mott, L. A. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology, 12(6), 612–9. doi: 10.1002/pon.742 .

3. Ahles, T. A., Li, Y., McDonald, B. C., Schwartz, G. N., Kaufman, P. A., Tsongalis, G. J., et al. (2014). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psycho-Oncology, 23(12), 1382–90. doi: 10.1002/pon.3545 .

4. Amidi, A., Wu, L. M., Agerbaek, M., Larsen, P. L., Pedersen, A. D., Mehlsen, M., et al. (2015a). Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients. Psycho-Oncology, 24(9), 1174–1180. doi: 10.1002/pon.3804 .

5. Amidi, A., Wu, L. M., Pedersen, A. D., Mehlsen, M., Pedersen, C. G., Rossen, P., et al. (2015b). Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 23(10), 2973–9. doi: 10.1007/s00520-015-2663-3 .

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study;Breast Cancer Research;2024-06-05

2. Volumetric brain assessment of long-term head and neck cancer survivors;Radiotherapy and Oncology;2024-02

3. Neurologic Complications in Adult Cancer Survivorship;Seminars in Neurology;2024-01-06

4. The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype;Experimental Neurology;2024-01

5. Neurocognitive Impairment in Non-Central Nervous System Cancer Survivors;Journal of Psychophysiology;2024-01-01